Table 1.
Quality assessment of trials of the evidence for ITNs for preventing malaria deaths in children <5 years old
Quality assessment |
Summary findings |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Directness |
Intervention |
Control |
||||||||
No. of studies | Design | Limitations | Consistency of results | Generalizability to population of interest | Generalizability to intervention of interest | No. of events | Denominator | No. of events | Denominator | Pooled RR (95% CI) |
ACCM: high outcome-specific quality | ||||||||||
3 | CRCT | Not blinded | Consistent, χ2 for heterogeneity (2 df) = 1.5 | High | High | 1412 | 47 886 | 1709 | 48 152 | 0.82 (0.75–0.90) |
Uncomplicated malaria incidence: high outcome-specific quality | ||||||||||
4 | CRCT | Not blinded | Inconsistent, χ2 for heterogeneity (3 df) = 9.39 | High | High | 543 | 30 602 | 1021 | 29 316 | 0.49a (0.44–0.54) |
Prevalence of malaria parasite infection: high outcome-specific quality | ||||||||||
6 | CRCT | Not blinded | Inconsistent, χ2 for heterogeneity (6 df) = 83.5 | High | High | 2183 | 3921 | 2665 | 4093 | 0.83a (0.64–0.88) |
CRCT, community randomized controlled trial.
aRandom effects model.